Computational chemistry for small molecule drug discovery
Location: United States, New York
Employees: 11-50
Total raised: $17M
Founded date: 2019
Investors 6
| Date | Name | Website |
| - | Notation C... | notation.v... |
| - | Creative D... | creativede... |
| - | Preface Ve... | prefaceven... |
| - | Refactor C... | refactor.c... |
| - | Endless Fr... | endlessfro... |
| - | Hawktail M... | hawktail.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.12.2021 | Seed | $15M | - |
| 14.10.2019 | Seed | $2M | - |
Mentions in press and media 4
| Date | Title | Description |
| 09.12.2021 | Redesign Science Raises $15 Million to Advance Computational Structure-Based Drug Discovery | Redesign Science, a platform technology company combining physics, computer science and biotechnology to advance new small molecule therapeutics, announced the successful completion of Seed-2 and Seed-3 financings, for a total of $15 millio... |
| 08.12.2021 | Redesign Science Raises $15M in Seed-2 and Seed-3 Funding | Redesign Science, a New York-based computational drug discovery, raised $15M in Seed-2 and Seed-3 funding. The round was led by Collaborative Fund and 5Y Capital, Notation Capital, Third Kind Venture Capital, Preface Ventures, Refactor Capi... |
| 08.12.2021 | Redesign Science Raises $15M to Advance Computational Structure-Based Drug Discovery | NEW YORK, Dec. 8, 2021 /PRNewswire/ -- Redesign Science, a platform technology company combining physics, computer science and biotechnology to advance new small molecule therapeutics, announced the successful completion of Seed-2 and Seed-... |
| 15.10.2019 | Daily funding roundup - October 14th, 2019 | Redesign Science has raised $2M; Latent AI secured $3.5M; Mogrify landed $16M Redesign Science: Redesign Science’s platform is working on to advance new small molecule therapeutics. Redesign Science has raised $2 million in seed funding led... |